These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24668904)

  • 1. Has cognitive behavioural therapy for psychosis been oversold?
    McKenna P; Kingdon D
    BMJ; 2014 Mar; 348():g2295. PubMed ID: 24668904
    [No Abstract]   [Full Text] [Related]  

  • 2. Multimodal prevention of first psychotic episode through N-acetyl-l-cysteine and integrated preventive psychological intervention in individuals clinically at high risk for psychosis: Protocol of a randomized, placebo-controlled, parallel-group trial.
    Schmidt SJ; Hurlemann R; Schultz J; Wasserthal S; Kloss C; Maier W; Meyer-Lindenberg A; Hellmich M; Muthesius-Digón A; Pantel T; Wiesner PS; Klosterkötter J; Ruhrmann S;
    Early Interv Psychiatry; 2019 Dec; 13(6):1404-1415. PubMed ID: 30784233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm or aggression. Study protocol and baseline characteristics of participants.
    O'Donoghue B; Francey SM; Nelson B; Ratheesh A; Allott K; Graham J; Baldwin L; Alvarez-Jimenez M; Thompson A; Fornito A; Polari A; Berk M; Macneil C; Crisp K; Pantelis C; Yuen HP; Harrigan S; McGorry P
    Early Interv Psychiatry; 2019 Aug; 13(4):953-960. PubMed ID: 30024100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive-behavioural therapy for psychosis.
    Taylor K
    Br J Psychiatry; 2003 Sep; 183():262. PubMed ID: 12949003
    [No Abstract]   [Full Text] [Related]  

  • 5. Cognitive-behavioural therapy for psychosis.
    Marlowe K
    Br J Psychiatry; 2003 Sep; 183():262-3. PubMed ID: 12949002
    [No Abstract]   [Full Text] [Related]  

  • 6. Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14-18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS).
    Pyle M; Broome MR; Joyce E; MacLennan G; Norrie J; Freeman D; Fowler D; Haddad PM; Shiers D; Hollis C; Smith J; Liew A; Byrne RE; French P; Peters S; Hudson J; Davies L; Emsley R; Yung A; Birchwood M; Longden E; Morrison AP
    Trials; 2019 Jul; 20(1):395. PubMed ID: 31272477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is cognitive-behavioural therapy a worthwhile treatment for psychosis?
    Turkington D; McKenna PJ
    Br J Psychiatry; 2003 Jun; 182():477-9. PubMed ID: 12777337
    [No Abstract]   [Full Text] [Related]  

  • 8. Cognitive-behavioural therapy for psychosis.
    Kingdon D
    Br J Psychiatry; 2004 Jan; 184():85-6; author reply 86. PubMed ID: 14702236
    [No Abstract]   [Full Text] [Related]  

  • 9. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
    Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
    Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis.
    Alvarez-Jiménez M; Parker AG; Hetrick SE; McGorry PD; Gleeson JF
    Schizophr Bull; 2011 May; 37(3):619-30. PubMed ID: 19900962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study.
    Morrison AP; Law H; Carter L; Sellers R; Emsley R; Pyle M; French P; Shiers D; Yung AR; Murphy EK; Holden N; Steele A; Bowe SE; Palmier-Claus J; Brooks V; Byrne R; Davies L; Haddad PM
    Lancet Psychiatry; 2018 May; 5(5):411-423. PubMed ID: 29605187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the evidence for antipsychotic medication and alternative psychosocial interventions for people with acute, non-affective psychosis?
    Jauhar S; Lawrie SM
    Lancet Psychiatry; 2022 Mar; 9(3):253-260. PubMed ID: 35114137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis.
    Bechdolf A; Müller H; Stützer H; Wagner M; Maier W; Lautenschlager M; Heinz A; de Millas W; Janssen B; Gaebel W; Michel TM; Schneider F; Lambert M; Naber D; Brüne M; Krüger-Özgürdal S; Wobrock T; Riedel M; Klosterkötter J;
    Schizophr Bull; 2011 Sep; 37 Suppl 2(Suppl 2):S111-21. PubMed ID: 21860040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of third wave cognitive therapies in the treatment of psychosis: a meta-review].
    Barbieri A; Visco-Comandini F
    Riv Psichiatr; 2020; 55(2):61-70. PubMed ID: 32202543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evidence map of interventions across premorbid, ultra-high risk and first episode phases of psychosis.
    Liu P; Parker AG; Hetrick SE; Callahan P; de Silva S; Purcell R
    Schizophr Res; 2010 Oct; 123(1):37-44. PubMed ID: 20558043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained antipsychotic effect of metacognitive training in psychosis: a randomized-controlled study.
    Favrod J; Rexhaj S; Bardy S; Ferrari P; Hayoz C; Moritz S; Conus P; Bonsack C
    Eur Psychiatry; 2014 Jun; 29(5):275-81. PubMed ID: 24176646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early onset psychosis: rationale and concept of a cognitive-behavioral intervention].
    Güttgemanns J; Büch A; Sevecke K; Döpfner M; Lehmkuhl G; Herrlich J; Müller K; Wiedemann G; Klingberg S; Bechdolf A
    Fortschr Neurol Psychiatr; 2011 Sep; 79(9):524-30. PubMed ID: 21870313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotics in adolescent-onset psychosis: a work in progress.
    James AC; Broome MR
    Lancet Psychiatry; 2017 Aug; 4(8):e16-e17. PubMed ID: 28748801
    [No Abstract]   [Full Text] [Related]  

  • 20. Early intervention in patients at ultra high risk of psychosis: benefits and risks.
    de Koning MB; Bloemen OJ; van Amelsvoort TA; Becker HE; Nieman DH; van der Gaag M; Linszen DH
    Acta Psychiatr Scand; 2009 Jun; 119(6):426-42. PubMed ID: 19392813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.